
Journal of Medicinal Chemistry p. 1086 - 1094 (1991)
Update date:2022-07-31
Topics:
Showell, Graham A.
Gibbons, Tracey L.
Kneen, Clare O.
MacLeod, Angus M.
Merchant, Kevin
et al.
Recent studies have described novel azabicycle-based muscarinic agonists which readily penetrate into the central nervous system and are capable of displaying high efficacy at cortical sites.The current paper describes the synthesis and biochemical assesment of semirigid muscarinic ligands which were used to map the requirements of the cortical muscarinic receptor and to study the degree of conformational flexibility required to cause receptor activation.Analogues 6 and 9 provide high-efficacy muscarinic agonist at cortical sites; however, C-alkylation on the tetrahydropyridine ring resulted in more rigid analogues and showed lower predicted efficacy.Molecular mechanics calculations indicated a preference for the E rotameric form.This conformation was also observed in the X-ray crystal structure of ethenyloxadiazole 12.The new compounds were tested in biochemical assay designed to measure receptor affinity and to predict cortical efficacy.
View MoreHangzhou TJM Chemical Trade Co., Ltd
Contact:86-571-88223276 86-13388481653
Address:2221#,Boyuexuan,1860# Binsheng Road,Binjiang District, Hangzhou CityZhejiang Province, 310051, P. R. China
Contact:+44 (0)161 367 9441
Address:
CGeneTech (Suzhou, China) Co., Ltd.
Contact:+86-512-62956962
Address:Room 101,Bld C11,218 Xinghu Rd.,Suzhou industrial Park
Contact:+86-571-86491666
Address:SHI XIANG ROAD
ANHUI CHEM-BRIGHT BIOENGINEERING CO.,LTD
Contact:86-561-4080321
Address:No.8 Lieshan Industrial Zone of Huaibei
Doi:10.1021/ja00967a011
(1966)Doi:10.1016/S0040-4020(01)01061-4
(2001)Doi:10.1021/ja01196a036
(1947)Doi:10.1021/ja01600a036
(1956)Doi:10.1021/ol502515b
(2014)Doi:10.1021/jm00092a020
(1992)